Company profile: SNIPR Biome
1.1 - Company Overview
Company description
- Provider of CRISPR-based microbial gene therapies that selectively target and eliminate hazardous bacteria without harming beneficial microbes; gut-directed gene therapy via engineered bacteria; CRISPR-Guided Vectors (CGV) for rapid, precise bacterial killing; platforms for in situ therapeutic protein and peptide production; backed by an extensive patent portfolio and research collaborations.
Products and services
- CRISPR-Guided Vectors (CGV™ Technology): Custom-engineered DNA-based vectors enable rapid, precise targeting and killing of specific bacteria using CRISPR guidance, forming the platform for selective microbial control
- CRISPR-based Microbial Gene Therapy: In vivo therapeutics subvert endogenous bacterial CRISPR machinery to eliminate hazardous bacteria while selectively sparing beneficial microbiota and treating microbial diseases
- Gut-directed Gene Therapy: Gut-specific engineered bacteria deliver therapeutic molecules directly to the gut, enabling targeted treatment within the gastrointestinal tract for precision intervention
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SNIPR Biome
Pangaea Oncology
HQ: Spain
Website
- Description: Provider of precision oncology and personalized medicine based on genetic analysis for cancer patients, offering molecular diagnostics across cancer types, clinical trials services, biomarker discovery, companion diagnostics (DX) platform validation, preclinical research and diagnostics, in-vitro drug/vaccine testing, and multiplex assays in non-blood biological fluids for diagnostic and predictive value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pangaea Oncology company profile →
Brammer Bio
HQ: United States
Website
- Description: Provider of CDMO services for cell and gene therapies, including viral vector process and analytical development, clinical and commercial manufacturing and fill-finish; full-service cell therapy cGMP manufacturing; translational research to standardize processes and analytics; and end-to-end mRNA development and manufacturing from plasmid production to cold-chain logistics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Brammer Bio company profile →
Iveric Bio
HQ: United States
Website
- Description: Provider of science-driven biopharmaceutical research and development focused on novel treatment options for retinal diseases with significant unmet medical needs, including age-related macular degeneration, developing therapeutic product candidates for age-related retinal diseases and gene therapy product candidates.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Iveric Bio company profile →
Agena Bioscience
HQ: United States
Website
- Description: Provider of molecular diagnostic genetic reagents and mass spectrometry-based analysis systems, including the MassARRAY System for high-throughput genetic analysis in pharmacogenomics, mutation profiling, liquid biopsy, and inherited disease testing; PGx panels and the VeriDose Core Panel; custom assay services; the Revolution Sample Prep System for cfDNA extraction; and the MassARRAY Insights reporting software network.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agena Bioscience company profile →
Day Zero Diagnostics
HQ: United States
Website
- Description: Provider of whole-genome sequencing–based tools and services for clinical pathogen detection, antimicrobial resistance profiling, and outbreak management, including Blood2Bac to enrich bacterial DNA directly from blood; Keynome ID for species identification; Keynome gAST for resistance profiling; MicrohmDB to support machine learning; and epiXact for pathogen relatedness insights for infection control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Day Zero Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SNIPR Biome
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SNIPR Biome
2.2 - Growth funds investing in similar companies to SNIPR Biome
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SNIPR Biome
4.2 - Public trading comparable groups for SNIPR Biome
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →